Article

78-week waiters: the story so far

The 78-week target may not have been met yet, but systems have made huge progress to bring the number down towards 10,000.

12 May 2023

At a glance

  • There has been significant progress against the target to have zero patients waiting over 78 weeks by April 2023. There are approximately 10,737 patient pathways currently over the threshold, having been as high as nearly 125,000 in 2021.
  • This follows hard work by systems and providers and comes despite urgent and emergency care pressures, challenging case mixes, an uneven regional split of long waiters and cancelled appointments and procedures due to industrial action.
  • More than one in five (21 per cent) of the 137 NHS providers where data is available had completely eliminated 18-month waits, while 95 providers (69 per cent) had fewer than 50.
  • We also hear from some NHS Confederation members on the challenge and how they have tackled it thus far.

Background

In January this year, our analysis looked at the progress systems had made to eliminate the number of people waiting for elective care of over 78 weeks and assessed the potential to reduce this number to zero by April. Since then, trusts have made substantial progress, although the figure for the end of March 2023 is 10,737.

A new data release on 11 May also broke the data down into ‘reason’ for delay. It shows that 21 per cent of the remaining patients had been offered a choice of another provider but did not take this up, or had chosen to wait longer than 78 weeks for ‘social’ reasons.

19 per cent are highlighted as ‘complex’, for whom it would not be clinically safe to move to another provider or for whom the procedure is clinically complex and can only be done on that site or by that clinician, while 2 per cent are waiting for a corneal transplant and directly affected by the global shortage of corneas.

The remaining 59 per cent do not fall into these categories and the reason is noted as ‘capacity’.

In September 2021, there were an estimated 124,911 patient pathways that extended over 78 weeks for treatment. The figure is now reported at 10,737, having been cut considerably from the 20,101 reported week ending 19 March. The above chart shows the trajectory of the two datasets we have available (the standard, referral-to-treatment dataset and the supplementary data that has been available on an ad-hoc basis).

We have spoken to some of our members about the recent work. In the latest release, Nottingham University Hospitals’ number of patients waiting over 78 weeks was 122, having been at 754 at the end of December, and 674 week ending 5 February, showing there had been a big push through 2023. The chief executive, Anthony May, told us:

“Thanks to the collective commitment, dedication, and creative thinking of colleagues, I am proud to say as a trust, we have seen and treated over 1,600 patients through quarter four. Many of these patients may have breached the 78-week wait by the end of March, however, we reduced the number of patients waiting over 18 months for planned treatment by 77 per cent, when compared against our original forecasts made at the start of the year.  In addition to delivering this reduction in our longest waiting patients, we have continued to focus on ensuring we perform our most clinically urgent and time critical surgeries. 

I would like to thank our system partners and the regional team for their continued support in delivering this significant achievement.”

At University Hospitals of Leicester, there have also been significant challenges. We heard from Richard Mitchell, chief executive at University Hospitals of Leicester, where the newly released number is 837 for 78-week pathways, having been as high as 3,500 last summer and still over 3,000 in January:

“Exiting the pandemic, the waiting list in Leicester had increased by over 87 per cent from pre-pandemic levels – which was already too high. The scale of our elective challenge was significant and remains so as we continue to have patients waiting far too long for care in our hospitals. Yet we can also be proud of the progress we are making. In the 12 months to March 2023, we have seen a continual reduction in our longest waiters and have treated over 18,000 patients who would have otherwise been waiting 104 weeks by now, and over 50,000 patients who would have been waiting 78 weeks.

Three key aspects of our improvement have been: improving our processes and productivity; increasing capacity in the right areas; and having the support of partners to help us improve.

The improvements we are seeing are due to the hard work of colleagues and partners across our hospitals, our system and beyond.

It has felt difficult, it has felt relentless and there will continue to be ups and downs. But we are seeing continued progress. We are excited about what we can achieve. And most importantly we are making a difference for patients."

As highlighted in the quotes above, the amount of activity is not simply the reduction in the number of people already waiting more than 78 weeks. Systems must also treat people on pathways that are approaching the threshold to avoid them rising above 78 weeks. This represents a significant amount of activity to simply maintain the status quo.

The chart below shows how many pathways have tipped over the 78-week threshold each week since the end of January. At that point, the task wasn’t in the mid-40,000 range (the total number of 78 week waiters), and was actually in the 90,000-100,000 range needing to meet NHS England’s zero target by the end of March. This shows the significant amount of work in 2023 to now have the number at less than 11,000.

Mitigating factors

There have been a number of constraints on progress despite the progress made by systems.

One impediment was the particularly challenging A&E performance across December and January, meaning beds or staff sometimes needed to be diverted away from electives to tackle urgent and emergency care pressures. This has been exacerbated by challenges discharging patients, with high bed occupancy rates and a lack of capital investment over the last decade hampering abilities for the service to tackle the backlogs.

A second challenge has been case mix. Data showing the mix of patients to be treated is not available publicly, only the split of specialty, which does not indicate complexity. However, we know there was a significant drive to validate the waiting list and book outpatient appointments before the end of January, with outpatient appointments and treatments completed before the end of March. Remaining pathways are therefore likely to have had higher levels of acuity, with the potential to have risen since they were originally booked in.

The below chart uses the figures for case mix for the end of February, as there are some inaccuracies with the March 2023 'incomplete commissioner' data:

From publicly available data, it is hard to identify the exact impact of industrial action on the target, but we do know that over 57,000 operations have had to be cancelled and over 426,000 outpatient appointments due to strikes since December, with services having experienced disruption. In addition to reduced activity, industrial action will have had a wider impact on costs, productivity and resources which can affect subsequent recovery activity.

The burden of 78-week waiters is also not even. In the latest supplementary data release, we can see that 21 per cent of providers reported zero patients at the end of March, as per the target, while 69 per cent of providers (95 of the 137 in the data) had less than 50.

Conclusion

While the target has not yet been met, it is clear systems have made significant progress in treating those waiting the longest for care. That hard work should be celebrated especially alongside mitigating circumstances such as challenging case mix, emergency pressures, an uneven burden and disrupted services following industrial action, and noting the considerable volumes of patients tipping over 78 weeks during 2023 to date.

There are more challenges to come, too. The ambition is to eliminate waits of over 65 weeks by March 2024, and then 52 weeks by March 2025. The latter represents 4.9 per cent of the overall waiting list at the moment and these large cohorts may produce an even greater challenge, despite concerted efforts to eliminate 78-week waits helping to make inroads.  

How is the NHS performing?

View our analysis of all of the latest NHS performance figures for a rounded view of how healthcare services are coping under immense pressure.